Anthony Howell, Howell A, Howell T
Anthony Howell, Howell A, Howell T
Professor of Medical Oncology, Manchester University
Verified email at picr.man.ac.uk
Title
Cited by
Cited by
Year
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 365 (9472), 1687-1717, 2005
58462005
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.
M Clarke, R Collins, S Darby, C Davies, P Elphinstone, E Evans, ...
Lancet 366 (9503), 2087, 2005
48122005
Tamoxifen for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 351 (9114), 1451-1467, 1998
33061998
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
EARLY BREAST CANCER TRIALISTS'COLLABORATIVE GROUP
The Lancet 339 (8784), 1-15, 1992
2572*1992
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer
A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, JF Forbes, ...
Lancet 365 (9453), 60-62, 2005
22902005
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 …
S Darby, P McGale, C Correa, C Taylor, R Arriagada, M Clarke, D Cutter, ...
Lancet 378 (9804), 1707, 2011
22442011
Polychemotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 352 (9132), 930-942, 1998
18331998
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC …
A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, JF Forbes, ...
Lancet 359, 2131-2139, 2005
15982005
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
R Peto, C Davies, J Godwin, R Gray, HC Pan, M Clarke, D Cutter, S Darby, ...
Lancet 379 (9814), 432, 2012
13282012
Adjuvant docetaxel for node-positive breast cancer
M Martin, T Pienkowski, J Mackey, M Pawlicki, JP Guastalla, C Weaver, ...
New England Journal of Medicine 352 (22), 2302-2313, 2005
12002005
Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind …
LS Rosen, D Gordon, M Kaminski, A Howell, A Belch, J Mackey, ...
Cancer journal (Sudbury, Mass.) 7 (5), 377, 2001
10752001
Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials
Early Breast Cancer Trialists’ Collaborative Group
N Engl j med 333 (22), 1444-1455, 1995
9671995
Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or …
LS Rosen, D Gordon, M Kaminski, A Howell, A Belch, J Mackey, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
9632003
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
T Arimidex
The lancet oncology 9 (1), 45-53, 2008
9392008
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer
A Goldhirsch, WC Wood, RD Gelber, AS Coates, B Thurlimann, HJ Senn
Journal of clinical oncology 21 (17), 3357-3365, 2003
9162003
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
J Cuzick, I Sestak, M Baum, A Buzdar, A Howell, M Dowsett, JF Forbes
The lancet oncology 11 (12), 1135-1141, 2010
8212010
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.
J Cuzick, JF Forbes, I Sestak, S Cawthorn, H Hamed, K Holli, A Howell, ...
The Lancet 360, 817-824, 2002
7822002
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment
A Howell, JFR Robertson, J Quaresma Albano, A Aschermannova, ...
Journal of Clinical Oncology 20 (16), 3396-3403, 2002
7792002
Dissociation between steroid receptor expression and cell proliferation in the human breast
RB Clarke, A Howell, CS Potten, E Anderson
Cancer research 57 (22), 4987-4991, 1997
7591997
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer: results of the ATAC …
ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group
Cancer 98 (9), 1802-1810, 2003
7132003
The system can't perform the operation now. Try again later.
Articles 1–20